Actavis generic prostate cancer drug Bicalutamide first to market in UK, Germany, France
Reykjavik, Iceland, 10 July 2008 — Actavis Group, the international generic pharmaceuticals company, today announced the launch of Bicalutamide tablets in the United Kingdom, Germany

